Navigation Links
Alcohol-breakdown molecule may play a role in breast cancer development
Date:2/11/2014

New research looking at the biological process involved in breast cancer development has strengthened the argument for a potential link between alcohol consumption and the disease.

Scientists from The University of Manchester part of the Manchester Cancer Research Centre and the University of Salford looked at a particular enzyme, a biological molecule that accelerates chemical reactions - known as CYP2E1.

Their findings offer a possible target to improve outcomes for patients in the later stages of the disease.

Dr Costas Demonacos, based at The University's Manchester Pharmacy School who led the research, said: "This enzyme, known as CYP2E1, has been implicated in various liver diseases linked to alcohol consumption (Alcoholic Liver Disease (ALD), as well as diabetes, obesity and cancer.

"We wanted to understand why an enzyme known to function mainly in the liver was found to be heavily present in some types of breast cancer tissues. We also wanted to explore what other activities this enzyme might have that control the development of breast cancer."

The enzyme breaks down various molecules within cells, including alcohol. The by-products of this metabolism include reactive oxygen species (ROS), resulting in something called oxidative stress - in normal physiological conditions this aids cellular functions, whereas when concentrations of ROS are high or oxidative stress becomes chronic, cells can be seriously damaged.

Previous studies have shown that the enzyme is most strongly expressed in early-stage breast tumours rather than more developed tumours and scientists believe that it contributes to the progression of breast cancer. The Manchester team looked at the role it plays in various cellular functions in breast cancer cells.

The study, published in Breast Cancer Research, found that depending on the stage of the breast cancer, high levels of the enzyme can help cells survive during stress.

They also found that inhibiting the activity of the enzyme in cells with high migratory potential promoted cell migration a process linked to cancer spreading known as metastasis.

Dr Demonacos said: "Now that we have a clearer picture of the role played by this enzyme in breast cancer development, scientists could use it as a target in the later stages of the disease, to slow down the spread of cancer as well as to personalise anti-cancer therapy.

"Since CYP2E1 is involved in alcohol metabolism too, our findings should allow new insight on the potential link between chronic alcohol consumption and breast cancer, by showing how alcohol influences the progression of cancer."


'/>"/>

Contact: Alison Barbuti
alison.barbuti@manchester.ac.uk
44-016-127-58383
University of Manchester
Source:Eurekalert

Related medicine news :

1. Molecule movements that make us think
2. Prions in the brain eliminated by homing molecules
3. Researchers identify a life-and-death molecule on chronic leukemia cells
4. Inhibitors of shuttle molecule show promise in acute leukemia
5. Mayo Clinic: Molecule thought cancer foe actually helps thyroid tumors grow
6. Cleveland Clinic researchers discover molecule that may prevent atherosclerosis
7. Molecule found that inhibits recovery from stroke
8. Molecule shows effectiveness against drug-resistant myeloma
9. Measuring molecules with the naked eye
10. New developments reveal a molecule with a promising function in terms of cancer treatment.
11. Fat molecule ceramide may factor in muscle loss in older adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... 21, 2017 , ... Hanna Boys Center http://www.hannacenter.org ... the keynote speaker at its second Professional Networking Breakfast on March 9, 2017. ... comprehensive strategies to create and expand opportunities for boys and young men of ...
(Date:2/21/2017)... ... February 21, 2017 , ... As recently as 2015, rhinoplasty was one of ... of Plastic Surgeons. Some patients want to make a change in the appearance of ... their breathing ability. The team at usrhinoplasty.org is expanding its article database ...
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... Ray Insurance ... communities in and around Tarrant County, is embarking on a six month charity event ... and treatments for cancer. , Cancer is one of the deadliest diseases in America; ...
(Date:2/21/2017)... ... February 21, 2017 , ... American Veterinarian™, the premier multimedia ... launching its first bi-monthly issue of 2017 in February. The inaugural issue will ... One Health. , In making the announcement, American Veterinarian™ Publisher Chris Hennessy ...
(Date:2/21/2017)... ... 2017 , ... Each February the nation reflects upon African ... American History Month ). This month-long celebration encourages reflection upon the ... people, but also the opportunity to examine the trends of addiction among African ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... Feb. 21, 2017  /PR Newswire/ -- UBM Medica,s ... announce the launch of Modern Retina ( ... retina specialists. Built upon the success of ... on the latest innovations in the areas of retinal ... management. By meeting current informational needs and filling existing ...
(Date:2/21/2017)... , Feb. 21, 2017   BeyondSpring ... on the development of innovative immuno-oncology cancer therapies, ... significant data from its Phase 2 trial of ... the treatment of non-small cell lung cancer (NSCLC) ... at this year,s ASCO-SITC Clinical Immuno-Oncology Symposium in ...
(Date:2/21/2017)... IDAHO FALLS, Idaho , Feb. 21, 2017 /PRNewswire/ ... is has completed a private placement with certain investors ... preferred stock of the Company, Series C Convertible Redeemable ... Stock accrues dividends at an annual rate of 6% ... share.  The Company plans to use the proceeds for ...
Breaking Medicine Technology: